A novel approach to paraneoplastic intestinal pseudo-obstruction

Supportive Care in Cancer

Volumn 20, Issue 2, 2012, Pages 425-428

  Badari, Ambuga ^a   Farolino, Deborah ^b   Nasser, Eiad ^a   Mehboob, Shahid ^b   Crossland, David ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

Anti Hu antibody; Cyclophosphamide; Paraneoplastic neuropathy; Rituximab

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; HU ANTIBODY; IMMUNOGLOBULIN; IRINOTECAN; METOCLOPRAMIDE; OCTREOTIDE; RITUXIMAB;

ADULT; ARTICLE; BARIUM ENEMA; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DYSPHAGIA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS ACHALASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUS; INTESTINE DISTENSION; INTESTINE PSEUDOOBSTRUCTION; JEJUNOSTOMY; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NEUROPATHY; PARANEOPLASTIC SYNDROME; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROCTOCOLECTOMY; RADIATION DOSE; SEROLOGY; SIGMOIDOSCOPY; SKULL IRRADIATION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE; WEIGHT REDUCTION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC POLYNEUROPATHY; QUALITY OF LIFE; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME;

EID: 84855192811     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1305-7     Document Type: Article

References (17)

1. J Honnorat JC Antoine 2007 Paraneoplastic neurological syndromes Orphanet J Rare Dis 2 22 17480225 10.1186/1750-1172-2-22
2. A Antonucci L Fronzoni L Cogliandro, et al. 2008 Chronic intestinal pseudo-obstruction World J Gastroenterol 14 2953 2961 18494042 10.3748/wjg.14.2953 1:CAS:528:DC%2BD1cXht1SqsbzO
3. HR Lee VA Lennon M Camilleri, et al. 2001 Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics Am J Gastroenterol 96 373 379 11232678 10.1111/j.1572-0241.2001.03454.x 1:STN:280: DC%2BD3M7ot12htQ%3D%3D
4. VA Lennon BMF SasDF 1991 Enteric neuronal auto antibodies in pseudo obstruction with small-cell lung carcinoma Gastroenterology 100 137 142 1845756 1:STN:280:DyaK3M%2FmtVSisA%3D%3D
5. DS Pardi SM Miller DL Miller 2002 Paraneoplastic dysmotility: loss of interstitial cells of Cajal Am J Gastroenterol 97 1828 1833 12135044 10.1111/j.1572-0241.2002.05851.x (Pubitemid 34761415)
6. R De Giorgio M Camilleri 2004 Human enteric neuropathies: morphology and molecular pathology Neurogastroenterol Motil 16 515 531 15500508 10.1111/j.1365-2982.2004.00538.x (Pubitemid 39472185)
7. R De Giorgio M Bovara G Barbara, et al. 2003 Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility Gastroenterology 125 70 79 12851872 10.1016/S0016-5085(03)00664-4 (Pubitemid 36799108)
8. CF Lucchinetti DW Kimmel VA Lennon 1998 Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies Neurology 50 652 657 9521251 1:STN:280:DyaK1c7otVGntQ%3D%3D
9. G Di Nardo C Blandizzi U Volta, et al. 2008 Molecular, pathological and therapeutic features of human enteric neuropathies Aliment Pharmacol Ther 28 25 42 18410560 10.1111/j.1365-2036.2008.03707.x (Pubitemid 351782813)
10. Martin F, Chan AC (2004) Pathogenic roles of B cells in human autoimmunity: insights from the clinic. Immunity 517-527 (Pubitemid 38638122)
11. R Stasi A Pagano E Stipa, et al. 2001 Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura Blood 98 952 957 11493438 10.1182/blood.V98.4.952 1:CAS:528:DC%2BD3MXmtFeis70%3D
12. A Reiner T Gernsheimer SJ Slichter 1995 Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura Blood 85 351 7811992 1:CAS:528:DyaK2MXjtVWitbk%3D
13. A Martin A Messineo P Lionetti, et al. 2008 A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy J Pediatr Gastroenterol Nutr 46 457 460 18367961 10.1097/MPG.0b013e31815a98ff (Pubitemid 351457883)
14. E Oton V Moreira C Redondo, et al. 2005 Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy? Gut 54 1343 1344 16099803 10.1136/gut.2005.071811 1:STN:280:DC%2BD2Mvjt1Glsw%3D%3D (Pubitemid 41192500)
15. CAM Drukker HA Heij LCD Wijnaendts, et al. 2009 Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma Pediatr Blood Cancer 52 396 398 18989884 10.1002/pbc.21807 1:STN:280:DC%2BD1M%2FntVOrtA%3D%3D
16. F Coret I Bosca L Fratalia, et al. 2009 Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction J Neurooncol 93 421 423 19139820 10.1007/s11060-008- 9787-y 1:CAS:528:DC%2BD1MXmsVClsbg%3D
17. S Shams'ili J Beukelaar JW Gratama 2006 An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes J Neurol 253 16 20 16444604 10.1007/s00415-005-0882-0 (Pubitemid 43157382)